Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 8/20 | 0.41 |
| ▸ | AGTR2 | P50052 | 7/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.39 |
| ▸ | GALR3 | O60755 | 1/20 | 0.36 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9871600 | 0.92 | AGTR1 (0.38) | AGTR1AGTR2PDE10A | |
| SCHEMBL9871103 | 0.87 | AGTR1 (0.42) | AGTR1AGTR2PDE10ATLR7 | |
| SCHEMBL9873834 | 0.87 | AGTR1 (0.35) | AGTR1AGTR2GP6 | |
| SCHEMBL9874500 | 0.85 | AGTR1 (0.38) | AGTR1AGTR2GP6 | |
| SCHEMBL9873895 | 0.84 | AGTR1 (0.40) | AGTR1AGTR2PDE10A | |
| SCHEMBL9871966 | 0.84 | AGTR1 (0.40) | AGTR1AGTR2PDE10ATLR7 | |
| SCHEMBL9873841 | 0.84 | AGTR1 (0.42) | AGTR1AGTR2 | |
| SCHEMBL9872663 | 0.84 | AGTR1 (0.53) | AGTR1AGTR2GP6 | |
| SCHEMBL9873359 | 0.84 | AGTR2 (0.39) | AGTR1AGTR2PDE10ATLR7 | |
| SCHEMBL9872890 | 0.84 | AGTR1 (0.41) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991019715-A1 | 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-12-26 | — | — | WO | disclosed |